Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early Trial
TUESDAY, April 9, 2024 (HealthDay News) — A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows. The vaccine could help liver cancer patients live longer, as fewer than one in 10 surviveContinue Reading